Atypical femoral fractures related to bisphosphonate therapy
نویسندگان
چکیده
منابع مشابه
Bisphosphonate-associated Atypical Fractures that are not “Atypical Femoral Fractures”
Aims: Responding to the steadily increasing number of unusual subtrochanteric and mid-shaft femoral (ST/FS) fractures in persons treated with the bisphosphonate drugs since the index cases were described in 2003, the American Society of Bone and Mineral Research (ASBMR) convened a committee tasked with finding a precise definition. Their present definition, a composite from two publications, in...
متن کاملAtypical femoral fractures and bisphosphonate use.
Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cush1. ing’s syndrome. Lancet 2006;367:1605-17. de Bruin C, Pereira AM, Feelders RA, et al. Coexpression of 2. dopamine and somatostatin receptor subtypes in corticotroph adenomas. J Clin Endocrinol Metab 2009;94:1118-24. Schmid HA. Pasireotide (SOM230): development, mecha3. nism of action and potential applications. Mol Cell Endocrinol 2008;2...
متن کاملBisphosphonate use and atypical fractures of the femoral shaft.
BACKGROUND Studies show conflicting results regarding the possible excess risk of atypical fractures of the femoral shaft associated with bisphosphonate use. METHODS In Sweden, 12,777 women 55 years of age or older sustained a fracture of the femur in 2008. We reviewed radiographs of 1234 of the 1271 women who had a subtrochanteric or shaft fracture and identified 59 patients with atypical fr...
متن کاملBisphosphonate-associated atypical femoral fractures and one-year mortality
Dear Editor, It is well known that osteoporotic fractures (OF) of the hip are associated with increased mortality, in particular immediately after the fracture (1). Although several theories have been proposed, the cause of the increase is not fully understood. In the past few years there have been an increasing number of reports of femoral fractures associated with bisphosphonate use (2). The ...
متن کاملAtypical femoral fractures associated with long-term bisphosphonate use.
1248 CMAJ, October 1, 2013, 185(14) © 2013 Canadian Medical Association or its licensors A75-year-old woman with osteoporosis presented with a 2-year history of anterior thigh pain that was worse when standing and walking. She had taken alendronate for more than 20 years, which was replaced with annual zoledronic acid infusions for the last 3 years. On examination, she had an antalgic gait. The...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Radiology and Imaging
سال: 2012
ISSN: 0971-3026
DOI: 10.4103/0971-3026.107178